References

Al-Marrawi MY, Saroya BS, Brennan MC, Yang Z, Dykes TM, El-Deiry WS. 2013. Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer. Cancer Biol Ther 14(8):703-710.

Aminkeng F, Bhavsar AP, Visscher H, Rassekh SR, Li Y, Lee JW, Brunham LR, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Amstutz U, Rieder MJ, Bernstein D, Carleton BC, Hayden MR, Ross CJ, and Canadian Pharmacogenomics Network for Drug Safety Consortium. 2015. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat Genet 47(9):1079-1084.

Arts FA, Chand D, Pecquet C, Velghe A, Constantinescu S, Hallberg B, Demoulin JB. 2016. PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib. Oncogene 35(25):3239-3248.

Baker M. 2016. 1,500 scientists lift the lid on reproducibility. Nature 533:452-454. Available at: https://www.nature.com/polopoly_fs/1.19970!/menu/main/topColumns/topLeftColumn/pdf/533452a.pdf (accessed April 6, 2018).

Begley CG, Ellis LM. 2012. Drug development: Raise standards for preclinical cancer research. Nature 483:531-533.

Benjamin D, Mandel DR, Kimmelman J. 2017. Can cancer researchers accurately judge whether preclinical reports will reproduce? PLoS Biol 15(6):e2002212. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2002212 (accessed December 13, 2017).

Burridge PW, Li YF, Matsa E, Wu H, Ong SG, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, Knowles JW, Telli ML, Witteles RM, Blau HM, Bernstein D, Altman RB, Wu JC. 2016. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med 22(5):547-556. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086256 (accessed April 6, 2018).

Church RJ, Gatti DM, Urban TJ, Long N, Yang X, Shi Q, Eaddy JS, Mosedale M, Ballard S, Churchill GA, Navarro V, Watkins PB, Threadgill DW, Harrill AH. 2015. Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food Chem Toxicol 76:19-26. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324012 (accessed April 8, 2018).

Clohessy JG, Pandolfi PP. 2015. Mouse hospital and co-clinical trial project—from bench to bedside. Nat Rev Clin Oncol 12(8):491-498.

Collins FS. 2010. A Genome Story: 10th Anniversary Commentary by Francis Collins. Scientific American. Available at: https://blogs.scientificamerican.com/guest-blog/a-genome-story-10th-anniversary-commentary-by-francis-collins (accessed April 6, 2018).

Concert Genetics. 2017. The Current Landscape of Genetic Testing. Available at: https://www.concertgenetics.com/wp-content/uploads/2017/05/10_ConcertGenetics_CurrentLandscapeofGeneticTesting_2017Update.pdf (accessed December 13, 2017).

De Geyter D, Stoop W, Sarre S, De Keyser J, Kooijman R. 2013. Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke. Neuroscience 250:253-262.

de Vries RB, Buma P, Leenaars M, Ritskes-Hoitinga M, Gordijn B. 2012. Reducing the number of laboratory animals used in tissue engineering research by restricting the variety of animal models. Articular cartilage tissue engineering as a case study. Tissue Eng Part B Rev 18(6):427-435.

Dickinson ME, Flenniken AM, Ji X, Teboul L, Wong MD, White JK, Meehan TF, Weninger WJ, Westerberg H, Adissu H, Baker CN, Bower L, Brown JM, Caddle LB, Chiani F, Clary D, Cleak J, Daly MJ, Denegre JM, Doe B, Dolan ME, Edie Helmut Fuchs SM, Gailus-Durner V, Galli A, Gambadoro A, Gallegos J, Guo S, Horner NR, Hsu CW, Johnson SJ, Kalaga S, Keith LC, Lanoue L, Lawson TN, Lek M, Mark M, Marschall S, Mason J, McElwee ML, Nutter SNLMJ, Peterson KA, Ramirez-Solis R, Rowland DJ, Ryder E, Samocha KE, Seavitt JR, Selloum M, Szoke-Kovacs Z, Tamura M, Trainor AG, Tudose I, Wakana S, Warren J, Wendling O, West DB, Wong L, Yoshiki A; International Mouse Phenotyping Consortium, Wurst W, MacArthur DG, Tocchini-Valentini GP, Gao X, Flicek P, Bradley A, Skarnes WC, Justice MJ, Parkinson HE, Moore M, Wells S, Braun RE, Svenson KL, de Angelis MH, Herault Y, Mohun T, Mallon AM, Henkelman RM, Brown SDM, Adams DJ, Lloyd KCK, McKerlie C, Beaudet AL, Murray MBSA. 2016. High-throughput discovery of novel developmental phenotypes. Nature 551(7680):398. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295821 (accessed April 6, 2018).

Dirnagl U. 2016. Is translational stroke research broken, and if so, how can we fix it? Stroke 47(8):2148-2153. Available at: http://stroke.ahajournals.org/content/47/8/2148.long (accessed April 6, 2018).

Dolgin E. 2013. Animal rule for drug approval creates a jungle of confusion. Nat Med 19(2):118-119.

Eddleston M, Cohen AF, Webb DJ. 2016. Implications of the BIA-102474-101 study for review of first-into-human clinical trials. Br J Clin Pharmacol 81(4):582-586. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799914 (accessed April 6, 2018).

Einsiedel EF. 2005. Public perceptions of transgenic animals. Rev Sci Tech 24(1):149-157.

Enserink M. 2017. Sloppy reporting on animal studies proves hard to change. Science 357(6358):1337-1338.

Freedman LP, Cockburn IM, Simcoe TS. 2015. The economics of reproducibility in preclinical research. PLoS Biol 13(6):e1002165. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002165 (accessed December 13, 2017).

Gallup News. 2017. Americans Hold Record Liberal Views on Most Moral Issues. Available at: http://news.gallup.com/poll/210542/americans-hold-record-liberal-views-moralissues.aspx (accessed December 13, 2017).

Gelman A, Loken E. 2014. The statistical crisis in science. American Scientist 102(6):460.

Harhausen D, Prinz V, Ziegler G, Gertz K, Endres M, Lehrach H, Gasque P, Botto M, Stahel PF, Dirnagl U, Nietfeld W, Trendelenburg G. 2010. CD93/AA4.1: A novel regulator of inflammation in murine focal cerebral ischemia. J Immunol 184(11):6407-6417. Available at: http://www.jimmunol.org/content/184/11/6407.long (accessed April 6, 2018).

Harris MH, DuBois SG, Glade Bender JL, Kim A, Crompton BD, Parker E, Dumont IP, Hong AL, Guo D, Church A, Stegmaier K, Roberts CW, Shusterman S, London WB, MacConaill LE, Lindeman NI, Diller L, Rodriguez-Galindo C, Janeway KA. 2016. Multicenter feasibility study of tumor molecular profiling to inform therapeutic decisions in advanced pediatric solid tumors: The Individualized Cancer Therapy (iCat) study. JAMA Oncol 2(5):608-615. Available at: https://jamanetwork.com/journals/jamaoncology/fullarticle/2484355 (accessed April 6, 2018).

Herman EH, el-Hage AN, Ferrans VJ, Ardalan B. 1985. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78(2):202-214.

Holman C, Piper SK, Grittner U, Diamantaras AA, Kimmelman J, Siegerink B, Dirnagl U. 2016. Where have all the rodents gone? The effects of attrition in experimental research on cancer and stroke. PLoS Biol 14(1):e1002331. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002331 (accessed April 6, 2018).

Horn J, de Haan RJ, Vermeulen M, Luiten PG, Limburg M. 2001. Nimodipine in animal model experiments of focal cerebral ischemia: A systematic review. Stroke 32(10):2433-2438. Available at: http://stroke.ahajournals.org/content/32/10/2433.long (accessed April 6, 2018).

Igarashi Y, Nakatsu N, Yamashita T, Ono A, Ohno Y, Urushidani T, Yamada H. 2015. Open TG-GATEs: A large-scale toxicogenomics database. Nucl Acid Res 43(Database issue): D921-D927. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384023 (accessed April 6, 2018).

Ioannidis JPA. 2005. Why most published research findings are false. PLoS Med 2(8):e124. Available at: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020124 (accessed December 13, 2017).

Jacobson LK, Johnson MB, Dedhia RD, Niknam-Bienia S, Wong AK. 2017. Impaired wound healing after radiation therapy: A systematic review of pathogenesis and treatment. JPRAS Open 13:92-105. Available at: https://www.sciencedirect.com/science/article/pii/S2352587817300256 (accessed April 6, 2018).

Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. 2010. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. Br J Pharmacol 160(7):1577-1579. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936830 (accessed April 6, 2018).

Langfelder P, Horvath S. 2008. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9:559. Available at: https://bmcbioinformatics.biomedcentral.com/articles/10.1186/1471-2105-9-559 (accessed April 6, 2018).

Lloyd KC, Robinson PN, MacRae CA. 2016. Animal-based studies will be essential for precision medicine. Sci Transl Med 8(352):352ed12. Available at: http://stm.sciencemag.org/content/8/352/352ed12.short (accessed April 6, 2018).

Manrai AK, Funke BH, Rehm HL, Olesen MS, Maron BA, Szolovits P, Margulies DM, Loscalzo J, Kohane IS. 2016. Genetic misdiagnoses and the potential for health disparities. N Engl J Med 375:655-665. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292722 (accessed April 6, 2018).

Manrai AK, Patel CJ, Ioannidis JPA, Kohane IS. 2018. The precarious wisdom of communal science (in preparation).

Mattina J, MacKinnon N, Henderson VC, Fergusson D, Kimmelman J. 2016. Design and reporting of targeted anticancer preclinical studies: A meta-analysis of animal studies investigating sorafenib antitumor efficacy. Cancer Res 76(16):4627-4636. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295843 (accessed April 6, 2018).

Minatogawa M, Takenouchi T, Tsuyusaki Y, Iwasaki F, Uehara T, Kurosawa K, Kosaki K, Curry CJ. 2017. Expansion of the phenotype of Kosaki overgrowth syndrome. Am J Med Genet 173(9):2422-2427.

Monticello TM, Jones TW, Dambach DM, Potter DM, Bolt MW, Liu M, Keller DA, Hart TK, Kadambi VJ. 2017. Current nonclinical testing paradigm enables safe entry to first-inhuman clinical trials: The IQ consortium nonclinical to clinical translational database. Toxicol Appl Pharmacol 334:100-109.

National Institutes of Health. 2015. The Precision Medicine Initiative. Available at: https://syndication.nih.gov/multimedia/pmi/infographics/pmi-infographic.pdf (accessed November 8, 2017).

NRC (National Research Council). 1988. Mapping and Sequencing the Human Genome. Washington, DC: National Academy Press. Available at: https://www.nap.edu/catalog/1097/mapping-and-sequencing-the-human-genome (accessed April 6, 2018).

NRC. 2011. Toward Precision Medicine. Washington, DC: The National Academies Press. Available at: https://www.nap.edu/catalog/13284/toward-precision-medicine-building-a-knowledge-network-for-biomedical-research (accessed April 6, 2018).

Olson H, Betton G, Robinson D, Monro TK, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, Dorato M, Van Deun K, Smith P, Berger B, Heller A. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32(1):56-67.

Paoloni M, Khanna C. 2008. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 8(2):147-156.

Pond D, Arts FA, Mendelsohn NJ, Demoulin JD, Scharer G, Messinger Y. 2018. A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib. Genet Med 20(1):142-150.

Popper K. 1959. The logic of scientific discovery. Available at: https://archive.org/details/PopperLogicScientificDiscovery (accessed December 14, 2017).

Prinz F, Schlange T, Asadullah K. 2011. Believe it or not: How much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10(9):712-713. Available at: https://www.nature.com/articles/nrd3439-c1 (accessed April 6, 2018).

Richter SH, Garner JP, Würbel H. 2009. Environmental standardization: Cure or cause of poor reproducibility in animal experiments? Nat Methods 6(4):257-261.

Russell WMS, Burch RL. 1959. The Principles of Humane Experimental Technique. London: Methuen.

Sena ES, van der Worp HB, Bath PMW, Howells DW, Macleod MR. 2010. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol. Available at: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1000344 (accessed December 13, 2017).

Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K. 2016. How stable are Parkinson’s disease subtypes in de novo patients: Analysis of the PPMI cohort. Parkinsonism Relat Disord 28:62-67.

Stern AM, Schurdak ME, Bahar I, Berg JM, Taylor DL. 2016. A perspective on implementing a quantitative systems pharmacology platform for drug discovery and the advancement of personalized medicine. J. Biomol Screen 21(6):521-534. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917453 (accessed April 8, 2018).

Strauss DG, Blinova K. 2017. Clinical trials in a dish. Trends Pharmacol Sci 38(1):4-7. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379998 (accessed April 8, 2018).

Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. 2006. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 355(10):1018-1028. Available at: http://www.nejm.org/doi/10.1056/NEJMoa063842?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov (accessed April 6, 2018).

Sutherland JJ, Jolly RA, Goldstein KM, Stevens JL. 2016. Assessing concordance of drug-induced transcriptional response in rodent liver and cultured hepatocytes. PLoS Comput Biol 12(3):e1004847. Available at: http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1004847 (accessed April 6, 2018).

Sutherland JJ, Webster YW, Willy JA, Searfoss GH, Goldstein KM, Irizarry AR, Hall DG, Stevens JL. 2017. Toxicogenomic module associations with pathogenesis: A network-based approach to understanding drug toxicity. Pharmacog J 1-14. Available at: https://www.nature.com/articles/tpj201717.pdf (accessed April 6, 2018).

Taylor M. 2017. Systematic Review: Concept and Tool Development with Application in the Integrated Risk Information System (IRIS) Assessment Process. Society of Toxicology Webinar November 8, 2017. Available at: http://www.toxicology.org/groups/ss/RASS/docs/RASS_Webinar_110817_Part2-IRIS_Taylor-REV.pdf (accessed March 28, 2018).

Thériault P, Le Béhot A, El Ali A, Rivest S. 2016. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Oncotarget 7(24):35552-35561. Available at: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=9652&pubmed-linkout=1 (accessed April 6, 2018).

Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC. 2009. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 301(8):831-841. Available at: https://jamanetwork.com/journals/jama/fullarticle/183453 (accessed April 6, 2018).

Tufts Center for the Study of Drug Development. 2015. Personalized medicine gains traction but still faces multiple challenges. Impact Report 17(3).

U.S. FDA (Food and Drug Administration). 2017. What We Do. Available at: https://www.fda.gov/aboutfda/whatwedo (accessed November 8, 2017).

Watson DE, Hunziker R, Wikswo JP. 2017. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Exp Biol Med (Maywood) 242(16):1559-1572. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661772 (accessed April 6, 2018).